|Petrozavodsk State University, Petrozavodsk, Lenin str. 33, VolkovaTO@yandex.ru|
|Petrozavodsk State University, Petrozavodsk, Lenin str. 33, firstname.lastname@example.org|
|Petrozavodsk State University, Petrozavodsk Lenin str. 33, email@example.com|
|N.N. Petrov Research Institute of Oncology, St.Petersburg, Leningradskaya str. 68, firstname.lastname@example.org|
diagnostic test systems
At present cervical cancer still remains one of the leading causes of cancer mortality among women. Diagnostic criteria for cervical cancer that are currently being used in clinical practice have a number of limitations in regard to the accuracy of diagnosis or ability to predict the course of the disease, and take no account of an individual status of a patient. To overcome these drawbacks, the development and introduction of new methods of molecular genetics and biochemical diagnostics, which are based upon analysis of changes of tissue biomarkers expression, into the clinics are required.